15/120
0.6 / 5 stars
All 120 Win/Lose results shown below
HURA Roast Me summary
TuHURA Biosciences, Inc./NV (HURA). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 24 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinHURA / S&P 30.73% / 15.20% |
LoseHURA / S&P HURA unavailable / 15.00% |
LoseHURA / S&P HURA unavailable / 50.40% |
| 2026-Q11/3 |
WinHURA / S&P 136.46% / -4.33% |
LoseHURA / S&P HURA unavailable / 11.30% |
LoseHURA / S&P HURA unavailable / 27.70% |
| 2025-Q40/3 |
LoseHURA / S&P -69.48% / 2.65% |
LoseHURA / S&P HURA unavailable / 9.00% |
LoseHURA / S&P HURA unavailable / 13.40% |
| 2025-Q31/3 |
WinHURA / S&P 11.21% / 8.12% |
LoseHURA / S&P HURA unavailable / 4.61% |
LoseHURA / S&P HURA unavailable / 13.45% |
| 2025-Q20/3 |
LoseHURA / S&P -30.96% / 10.94% |
LoseHURA / S&P HURA unavailable / 4.83% |
LoseHURA / S&P HURA unavailable / 10.63% |
| 2025-Q10/3 |
LoseHURA / S&P -21.03% / -4.27% |
LoseHURA / S&P HURA unavailable / 4.98% |
LoseHURA / S&P HURA unavailable / 10.57% |
| 2024-Q40/3 |
LoseHURA / S&P -40.07% / 2.41% |
LoseHURA / S&P HURA unavailable / 5.25% |
LoseHURA / S&P HURA unavailable / 6.15% |
| 2024-Q30/3 |
LoseHURA / S&P -27.78% / 5.89% |
LoseHURA / S&P HURA unavailable / 5.89% |
LoseHURA / S&P HURA unavailable / 6.11% |
| 2024-Q21/3 |
WinHURA / S&P 159.62% / 4.28% |
LoseHURA / S&P HURA unavailable / 5.38% |
LoseHURA / S&P HURA unavailable / 5.12% |
| 2024-Q10/3 |
LoseHURA / S&P -38.82% / 10.56% |
LoseHURA / S&P HURA unavailable / 5.71% |
LoseHURA / S&P HURA unavailable / 5.59% |
| 2023-Q40/3 |
LoseHURA / S&P -95.79% / 11.69% |
LoseHURA / S&P HURA unavailable / 6.81% |
LoseHURA / S&P HURA unavailable / 7.78% |
| 2023-Q31/3 |
WinHURA / S&P 0.25% / -3.27% |
LoseHURA / S&P HURA unavailable / 7.52% |
LoseHURA / S&P HURA unavailable / -5.03% |
| 2023-Q21/3 |
WinHURA / S&P 14.20% / 8.74% |
LoseHURA / S&P HURA unavailable / 9.50% |
LoseHURA / S&P HURA unavailable / -8.57% |
| 2023-Q10/3 |
LoseHURA / S&P -48.78% / 7.50% |
LoseHURA / S&P HURA unavailable / 10.77% |
LoseHURA / S&P HURA unavailable / -15.69% |
| 2022-Q41/3 |
WinHURA / S&P 27.59% / 7.56% |
LoseHURA / S&P HURA unavailable / 11.88% |
LoseHURA / S&P HURA unavailable / -17.99% |
| 2022-Q30/3 |
LoseHURA / S&P -61.15% / -4.88% |
LoseHURA / S&P HURA unavailable / 13.47% |
LoseHURA / S&P HURA unavailable / -1.41% |
| 2022-Q20/3 |
LoseHURA / S&P -30.15% / -16.10% |
LoseHURA / S&P HURA unavailable / 13.71% |
LoseHURA / S&P HURA unavailable / 11.04% |
| 2022-Q10/3 |
LoseHURA / S&P -21.96% / -4.60% |
LoseHURA / S&P HURA unavailable / 15.97% |
LoseHURA / S&P HURA unavailable / 42.23% |
| 2021-Q40/3 |
LoseHURA / S&P -40.70% / 11.03% |
LoseHURA / S&P HURA unavailable / 15.00% |
LoseHURA / S&P HURA unavailable / 96.40% |
| 2021-Q30/3 |
LoseHURA / S&P -62.11% / 0.58% |
LoseHURA / S&P HURA unavailable / 10.77% |
LoseHURA / S&P HURA unavailable / 69.42% |
| 2021-Q21/3 |
WinHURA / S&P 30.46% / 8.55% |
LoseHURA / S&P HURA unavailable / 6.58% |
LoseHURA / S&P HURA unavailable / 51.81% |
| 2021-Q11/3 |
WinHURA / S&P 35.94% / 6.17% |
LoseHURA / S&P HURA unavailable / -1.06% |
LoseHURA / S&P HURA unavailable / 7.39% |
| 2020-Q40/3 |
LoseHURA / S&P -8.57% / 12.15% |
LoseHURA / S&P HURA unavailable / -3.72% |
LoseHURA / S&P HURA unavailable / -33.42% |
| 2020-Q31/3 |
WinHURA / S&P 103.49% / 8.93% |
LoseHURA / S&P HURA unavailable / -2.04% |
LoseHURA / S&P HURA unavailable / -27.10% |
| 2020-Q21/3 |
WinHURA / S&P 72.86% / 20.54% |
LoseHURA / S&P HURA unavailable / -0.46% |
LoseHURA / S&P HURA unavailable / -27.11% |
| 2020-Q10/3 |
LoseHURA / S&P -42.32% / -19.60% |
LoseHURA / S&P HURA unavailable / 3.47% |
LoseHURA / S&P HURA unavailable / -14.75% |
| 2019-Q41/3 |
WinHURA / S&P 24.77% / 9.07% |
LoseHURA / S&P HURA unavailable / 5.36% |
LoseHURA / S&P HURA unavailable / 2.99% |
| 2019-Q30/3 |
LoseHURA / S&P -57.13% / 1.70% |
LoseHURA / S&P HURA unavailable / 5.02% |
LoseHURA / S&P HURA unavailable / 0.21% |
| 2019-Q20/3 |
LoseHURA / S&P -73.67% / 4.30% |
LoseHURA / S&P HURA unavailable / 6.64% |
LoseHURA / S&P HURA unavailable / 8.65% |
| 2019-Q11/3 |
WinHURA / S&P 43.27% / 13.65% |
LoseHURA / S&P HURA unavailable / 8.12% |
LoseHURA / S&P HURA unavailable / 14.29% |
| 2018-Q40/3 |
LoseHURA / S&P -53.02% / -13.52% |
LoseHURA / S&P HURA unavailable / 9.05% |
LoseHURA / S&P HURA unavailable / 18.23% |
| 2018-Q30/3 |
LoseHURA / S&P 6.59% / 7.71% |
LoseHURA / S&P HURA unavailable / 10.21% |
LoseHURA / S&P HURA unavailable / 19.06% |
| 2018-Q20/3 |
LoseHURA / S&P -27.34% / 3.43% |
LoseHURA / S&P HURA unavailable / 9.03% |
LoseHURA / S&P HURA unavailable / 14.46% |
| 2018-Q10/3 |
LoseHURA / S&P -13.76% / -0.76% |
LoseHURA / S&P HURA unavailable / 7.68% |
LoseHURA / S&P HURA unavailable / 12.46% |
| 2017-Q41/3 |
WinHURA / S&P 29.76% / 6.64% |
LoseHURA / S&P HURA unavailable / 7.03% |
LoseHURA / S&P HURA unavailable / 13.82% |
| 2017-Q30/3 |
LoseHURA / S&P -63.32% / 4.48% |
LoseHURA / S&P HURA unavailable / 5.68% |
LoseHURA / S&P HURA unavailable / 17.57% |
| 2017-Q20/3 |
LoseHURA / S&P -45.48% / 3.09% |
LoseHURA / S&P HURA unavailable / 4.83% |
LoseHURA / S&P HURA unavailable / 17.74% |
| 2017-Q11/3 |
WinHURA / S&P 31.70% / 6.07% |
LoseHURA / S&P HURA unavailable / 3.67% |
LoseHURA / S&P HURA unavailable / 13.32% |
| 2016-Q40/3 |
LoseHURA / S&P -47.29% / 3.82% |
LoseHURA / S&P HURA unavailable / 2.09% |
LoseHURA / S&P HURA unavailable / 7.05% |
| 2016-Q30/3 |
LoseHURA / S&P -22.93% / 3.85% |
LoseHURA / S&P HURA unavailable / 0.20% |
LoseHURA / S&P HURA unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | HURA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -22.40% | 20.78% |
| Annualized return | -22.40% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | HURA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.92% | 83.14% |
| Annualized return | -76.15% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | HURA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -100.00% | 319.30% |
| Annualized return | -66.78% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-24.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |